Thomas A Schwann1, Abdul Karim M El Hage Sleiman2, Maroun B Yammine2, Robert F Tranbaugh3, Milo Engoren4, Mark R Bonnell5, Robert H Habib6. 1. Department of Surgery, University of Toledo, Toledo, Ohio; Department of Surgery, Mercy Saint Vincent Medical Center, Toledo, Ohio. Electronic address: thomas.schwann@utoledo.edu. 2. Scholars in Health Research Program, American University of Beirut, Beirut, Lebanon. 3. Department of Surgery, Weill Cornell Medicine, New York, New York. 4. Department of Anesthesiology, University of Michigan Medical Center, Ann Arbor, Michigan. 5. Department of Surgery, University of Toledo, Toledo, Ohio. 6. The Society of Thoracic Surgeons Research Center, Chicago, Illinois.
Abstract
BACKGROUND: We investigated whether extended arterial grafting with three or more arterial grafts in patients with a left internal thoracic artery to left anterior descending artery graft improves survival in coronary artery bypass graft surgery patients and whether its effects will depend on the extent of coronary artery disease; specifically three-vessel disease (3VD) versus two-vessel disease (2VD). METHODS: Fifteen-year mortality was analyzed in 11,931 patients with multivessel disease and primary isolated left internal thoracic artery to left anterior descending artery coronary artery bypass graft surgery with 2 or more grafts. Patients were aged 64.3 ± 10.5 years; 3,484 (29.2%) were women; 2,532 (21.2%) had 2VD and 9,399 (78.8%) had 3VD. Patients were grouped into one single-artery group (n = 6,782, 56.9%; reference group), and two multiple artery groups: two arteries (n = 3,678, 30.8%) and three arteries (n = 1,471, 12.3%). Long-term survival was compared by Kaplan-Meier estimates. Risk-adjusted mortality hazard ratio (HR) with 95% confidence interval (CI) were derived by covariate adjusted Cox regression to quantify multiple artery effects versus one artery in the overall cohort and separately among patients with 2VD and 3VD. RESULTS: Radial artery (94%) and right internal thoracic artery (6%) conduits were used for additional arterial grafts. For the entire multivessel cohort, increasing number of arterial grafts was associated with incrementally improved 15-year survival (two arteries HR 0.85, 95% CI: 0.78 to 0.92; three arteries HR 0.75, 95% CI: 0.65 to 0.85). The three arteries versus two arteries comparison was consistent, even if not significant (HR 0.89, 95% CI: 0.77 to 1.03). The benefits derived from additional arterial grafts were more pronounced in case of 3VD (two arteries HR 0.84 95% CI: 0.76 to 0.92; three arteries HR 0.73, 95% CI: 0.63 to 0.84), without survival benefit with 2VD. CONCLUSIONS: Our results support the use of extended arterial grafting to maximize long-term coronary artery bypass graft surgery patient survival, especially for 3VD patients.
BACKGROUND: We investigated whether extended arterial grafting with three or more arterial grafts in patients with a left internal thoracic artery to left anterior descending artery graft improves survival in coronary artery bypass graft surgery patients and whether its effects will depend on the extent of coronary artery disease; specifically three-vessel disease (3VD) versus two-vessel disease (2VD). METHODS: Fifteen-year mortality was analyzed in 11,931 patients with multivessel disease and primary isolated left internal thoracic artery to left anterior descending artery coronary artery bypass graft surgery with 2 or more grafts. Patients were aged 64.3 ± 10.5 years; 3,484 (29.2%) were women; 2,532 (21.2%) had 2VD and 9,399 (78.8%) had 3VD. Patients were grouped into one single-artery group (n = 6,782, 56.9%; reference group), and two multiple artery groups: two arteries (n = 3,678, 30.8%) and three arteries (n = 1,471, 12.3%). Long-term survival was compared by Kaplan-Meier estimates. Risk-adjusted mortality hazard ratio (HR) with 95% confidence interval (CI) were derived by covariate adjusted Cox regression to quantify multiple artery effects versus one artery in the overall cohort and separately among patients with 2VD and 3VD. RESULTS: Radial artery (94%) and right internal thoracic artery (6%) conduits were used for additional arterial grafts. For the entire multivessel cohort, increasing number of arterial grafts was associated with incrementally improved 15-year survival (two arteries HR 0.85, 95% CI: 0.78 to 0.92; three arteries HR 0.75, 95% CI: 0.65 to 0.85). The three arteries versus two arteries comparison was consistent, even if not significant (HR 0.89, 95% CI: 0.77 to 1.03). The benefits derived from additional arterial grafts were more pronounced in case of 3VD (two arteries HR 0.84 95% CI: 0.76 to 0.92; three arteries HR 0.73, 95% CI: 0.63 to 0.84), without survival benefit with 2VD. CONCLUSIONS: Our results support the use of extended arterial grafting to maximize long-term coronary artery bypass graft surgery patient survival, especially for 3VD patients.
Authors: David Glineur; William D'hoore; Joel Price; Sarah Dorméus; Laurent de Kerchove; Robert Dion; Philippe Noirhomme; Gebrine El Khoury Journal: Eur J Cardiothorac Surg Date: 2012-01-26 Impact factor: 4.191
Authors: Robert F Tranbaugh; Kamellia R Dimitrova; Patricia Friedmann; Charles M Geller; Loren J Harris; Paul Stelzer; Bertram Cohen; Darryl M Hoffman Journal: Ann Thorac Surg Date: 2010-10 Impact factor: 4.330
Authors: Michele Di Mauro; Marco Contini; Angela L Iacò; Antonio Bivona; Massimo Gagliardi; Egidio Varone; Paolo Bosco; Antonio M Calafiore Journal: J Thorac Cardiovasc Surg Date: 2009-02-07 Impact factor: 5.209
Authors: Mario Gaudino; John D Puskas; Antonino Di Franco; Lucas B Ohmes; Mario Iannaccone; Umberto Barbero; David Glineur; Juan B Grau; Umberto Benedetto; Fabrizio D'Ascenzo; Fiorenzo Gaita; Leonard N Girardi; David P Taggart Journal: Circulation Date: 2017-01-24 Impact factor: 29.690
Authors: Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Bruce W Lytle; Eugene H Blackstone; Joseph F Sabik; Penny Houghtaling; Floyd D Loop; Delos M Cosgrove Journal: Ann Thorac Surg Date: 2004-12 Impact factor: 4.330
Authors: Paul A Kurlansky; Ernest A Traad; Malcolm J Dorman; David L Galbut; Melinda Zucker; George Ebra Journal: Ann Thorac Surg Date: 2010-07 Impact factor: 4.330
Authors: Siamak Mohammadi; François Dagenais; Pierre Voisine; Eric Dumont; Eric Charbonneau; Mohamed Marzouk; Andreas Paramythiotis; Dimitri Kalavrouziotis Journal: Ann Thorac Surg Date: 2015-11-11 Impact factor: 4.330
Authors: David P Taggart; Douglas G Altman; Marcus Flather; Stephen Gerry; Alastair Gray; Belinda Lees; Umberto Benedetto Journal: Circulation Date: 2017-05-31 Impact factor: 29.690